Actio launches dedicated patient resource to support families seeking information about the KYRON clinical trial at ...
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), today announced that it has reached a mutual agreement with Garda Therapeutics, Inc. (“Garda”) to delay the launch of the ...
Prestigious international awards program recognizes standout digital health and medical technology innovationsOVERLAND PARK, ...
SGD Pharma, a global leader in cosmetic and pharmaceutical glass packaging, is proud to announce its participation in LuxePack New York 2026, held on 6–7 May at Javits Center, Booth C10.This ...
In the pivotal Phase 3 POETYK PsA clinical trials, Sotyktu demonstrated superiority compared with placebo at Week 16 across multiple endpoints, including skin and joint symptoms, with improvements in ...
Landmark 10th Annual Awards Program Recognizes the Deseyne® Extended Depth of Focus (EDOF) contact lens as the “Best New ...
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing ...
Growing adoption of digital technologies in life science; expansion of real-world evidence data and its adoption by ...
SAN FRANCISCO, CA / ACCESS Newswire / May 8, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today provided an update on the status of the Company's listing on The Nasdaq Stock ...
VANCOUVER, BC / ACCESS Newswire / May 8, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that Nucro-Technics Inc.
In SAM et al. v. Kennedy (1:26-cv-01081), the Court Weighs Whether CMS Overstepped Its Authority by allowing Hemp, Marijuana Cannabinoid Access Without FDA Approval.Duane Boise, CEO of MMJ ...
"As a Federal Lawsuit Challenges the CMS Cannabinoid Program, Questions Mount Over Safety Standards, Scientific Validation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results